Research on precise diagnosis and treatment of cervical spondylotic myelopathy and construction of multidisciplinary collaboration platform

Department of orthopedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Signed informed consent form;
•2. The patients who meet the diagnostic criteria belong to mild or moderate cervical spondylotic myelopathy;
•3. Male or female aged 40-75 years;
•4. The course of disease is more than 3 months;
•5. Volunteer to receive the treatment (Yiqi Huayu tongsui granules or placebo drugs combined with Bokebao).
•6. The patients didn't received glucocorticoids orally, intravenously, intramuscularly or in soft tissue 4 weeks before accepting the test drug.

•1. Those who have participated in or are participating in other clinical researches in the past 3 months;
•2. The patients who had been treated with regular non-surgical treatment for at least 6 months to no avail and had more severe symptoms;
•3. The muscle strength decreased significantly in a short period of time, and the muscle strength was lower than grade III;
•4. Patients with history of severe cervical trauma and cervical surgery;
•5. Pregnant women, lactating women and psychopaths;
•6. Patients with heart, liver, kidney or hematopoiesis impairment;
•7. People who are allergic to various drugs;
•8. Mentally or legally disabled;
•9. Those who have a history of opioid analgesics, sedative hypnotics and alcohol abuse;
•10. Patients with serious primary diseases such as liver, kidney, hematopoietic system, endocrine system, cardio cerebrovascular system, nervous system, tuberculosis, vertebral deformity, malignant tumor and psychosis;
•11. Those who do not read or write in Chinese.

发起方

Department of orthopedics, Longhua Hospital, Shanghai University of Traditional Chinese Medicine